EGFR mutation testing in non-small cell lung cancer (NSCLC)

Highlights ► EGFR mutation is a useful target for lung cancer treatment. ► All non-squamous lung cancer cases especially adenocarcinoma should be tested for EGFR mutation. ► Determining the histological subtype of non-small cell lung cancer is critical first step in the management of this disease....

Full description

Saved in:
Bibliographic Details
Published inJournal of infection and public health Vol. 5; pp. S31 - S34
Main Author Al Dayel, Fouad
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.12.2012
Elsevier
Subjects
Adenocarcinoma of lung
Carcinoma, Non-Small-Cell Lung - diagnosis
Carcinoma, Non-Small-Cell Lung - pathology
EGFR mutation
Humans
Infectious Disease
Internal Medicine
Lung Neoplasms - diagnosis
Lung Neoplasms - pathology
Mutation
Receptor, Epidermal Growth Factor - genetics
Targeted therapy
EGFR mutation
Targeted therapy
Adenocarcinoma of lung
Online AccessGet full text

Cover

More Information
Summary:Highlights ► EGFR mutation is a useful target for lung cancer treatment. ► All non-squamous lung cancer cases especially adenocarcinoma should be tested for EGFR mutation. ► Determining the histological subtype of non-small cell lung cancer is critical first step in the management of this disease.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Instructional Material/Guideline-2
ObjectType-Feature-3
content type line 23
ISSN:1876-0341
1876-035X
DOI:10.1016/j.jiph.2012.09.008